Home
About
Overview
Sharing Data
ORCID
Help
History (11)
Recurrent fungal pneumonias in patients with acute nonlymphocytic leukemia undergoing multiple courses of intensive chemotherapy.
Antibody targeting tumor-derived soluble NKG2D ligand sMIC provides dual co-stimulation of CD8 T cells and enables sMIC+ tumors respond to PD1/PD-L1 blockade therapy.
Afatinib as second-line treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Subgroup analyses of treatment adherence, safety and mode of afatinib administration in the LUX-Head and Neck 1 trial.
Guanosine Diphosphate
A cost-effectiveness analysis of first-line controller therapies for persistent asthma.
See All 11 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A cost-effectiveness analysis of first-line controller therapies for persistent asthma.
A cost-effectiveness analysis of first-line controller therapies for persistent asthma. Pharmacoeconomics. 2007; 25(7):577-90.
View in:
PubMed
subject areas
Anti-Asthmatic Agents
Asthma
Cost-Benefit Analysis
Decision Support Techniques
Drug Combinations
Female
Humans
Male
Managed Care Programs
Models, Economic
Randomized Controlled Trials as Topic